Global ADHD Medication Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global ADHD Medication Market Size 2017-2028

2.1.2 ADHD Medication Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 ADHD Medication Segment by Type

2.2.1 Stimulant

2.2.2 Non-stimulant

2.3 ADHD Medication Market Size by Type

2.3.1 ADHD Medication Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global ADHD Medication Market Size Market Share by Type (2017-2022)

2.4 ADHD Medication Segment by Application

2.4.1 Attention Deficit

2.4.2 Hyperactivity/impulse Control Disorder

2.4.3 Hybrid

2.5 ADHD Medication Market Size by Application

2.5.1 ADHD Medication Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global ADHD Medication Market Size Market Share by Application (2017-2022)

3 ADHD Medication Market Size by Player

3.1 ADHD Medication Market Size Market Share by Players

3.1.1 Global ADHD Medication Revenue by Players (2020-2022)

3.1.2 Global ADHD Medication Revenue Market Share by Players (2020-2022)

3.2 Global ADHD Medication Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 ADHD Medication by Regions

4.1 ADHD Medication Market Size by Regions (2017-2022)

4.2 Americas ADHD Medication Market Size Growth (2017-2022)

4.3 APAC ADHD Medication Market Size Growth (2017-2022)

4.4 Europe ADHD Medication Market Size Growth (2017-2022)

4.5 Middle East & Africa ADHD Medication Market Size Growth (2017-2022)

5 Americas

5.1 Americas ADHD Medication Market Size by Country (2017-2022)

5.2 Americas ADHD Medication Market Size by Type (2017-2022)

5.3 Americas ADHD Medication Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC ADHD Medication Market Size by Region (2017-2022)

6.2 APAC ADHD Medication Market Size by Type (2017-2022)

6.3 APAC ADHD Medication Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe ADHD Medication by Country (2017-2022)

7.2 Europe ADHD Medication Market Size by Type (2017-2022)

7.3 Europe ADHD Medication Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa ADHD Medication by Region (2017-2022)

8.2 Middle East & Africa ADHD Medication Market Size by Type (2017-2022)

8.3 Middle East & Africa ADHD Medication Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global ADHD Medication Market Forecast

10.1 Global ADHD Medication Forecast by Regions (2023-2028)

10.1.1 Global ADHD Medication Forecast by Regions (2023-2028)

10.1.2 Americas ADHD Medication Forecast

10.1.3 APAC ADHD Medication Forecast

10.1.4 Europe ADHD Medication Forecast

10.1.5 Middle East & Africa ADHD Medication Forecast

10.2 Americas ADHD Medication Forecast by Country (2023-2028)

10.2.1 United States ADHD Medication Market Forecast

10.2.2 Canada ADHD Medication Market Forecast

10.2.3 Mexico ADHD Medication Market Forecast

10.2.4 Brazil ADHD Medication Market Forecast

10.3 APAC ADHD Medication Forecast by Region (2023-2028)

10.3.1 China ADHD Medication Market Forecast

10.3.2 Japan ADHD Medication Market Forecast

10.3.3 Korea ADHD Medication Market Forecast

10.3.4 Southeast Asia ADHD Medication Market Forecast

10.3.5 India ADHD Medication Market Forecast

10.3.6 Australia ADHD Medication Market Forecast

10.4 Europe ADHD Medication Forecast by Country (2023-2028)

10.4.1 Germany ADHD Medication Market Forecast

10.4.2 France ADHD Medication Market Forecast

10.4.3 UK ADHD Medication Market Forecast

10.4.4 Italy ADHD Medication Market Forecast

10.4.5 Russia ADHD Medication Market Forecast

10.5 Middle East & Africa ADHD Medication Forecast by Region (2023-2028)

10.5.1 Egypt ADHD Medication Market Forecast

10.5.2 South Africa ADHD Medication Market Forecast

10.5.3 Israel ADHD Medication Market Forecast

10.5.4 Turkey ADHD Medication Market Forecast

10.5.5 GCC Countries ADHD Medication Market Forecast

10.6 Global ADHD Medication Forecast by Type (2023-2028)

10.7 Global ADHD Medication Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Takeda

11.1.1 Takeda Company Information

11.1.2 Takeda ADHD Medication Product Offered

11.1.3 Takeda ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Takeda Main Business Overview

11.1.5 Takeda Latest Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Information

11.2.2 Johnson & Johnson ADHD Medication Product Offered

11.2.3 Johnson & Johnson ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Johnson & Johnson Main Business Overview

11.2.5 Johnson & Johnson Latest Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis ADHD Medication Product Offered

11.3.3 Novartis ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Novartis Main Business Overview

11.3.5 Novartis Latest Developments

11.4 Eli Lilly

11.4.1 Eli Lilly Company Information

11.4.2 Eli Lilly ADHD Medication Product Offered

11.4.3 Eli Lilly ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Eli Lilly Main Business Overview

11.4.5 Eli Lilly Latest Developments

11.5 Tris Pharma, Inc

11.5.1 Tris Pharma, Inc Company Information

11.5.2 Tris Pharma, Inc ADHD Medication Product Offered

11.5.3 Tris Pharma, Inc ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Tris Pharma, Inc Main Business Overview

11.5.5 Tris Pharma, Inc Latest Developments

11.6 Neos Therapeutics

11.6.1 Neos Therapeutics Company Information

11.6.2 Neos Therapeutics ADHD Medication Product Offered

11.6.3 Neos Therapeutics ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Neos Therapeutics Main Business Overview

11.6.5 Neos Therapeutics Latest Developments

11.7 Mallinckrodt

11.7.1 Mallinckrodt Company Information

11.7.2 Mallinckrodt ADHD Medication Product Offered

11.7.3 Mallinckrodt ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Mallinckrodt Main Business Overview

11.7.5 Mallinckrodt Latest Developments

11.8 Amneal Pharmaceuticals

11.8.1 Amneal Pharmaceuticals Company Information

11.8.2 Amneal Pharmaceuticals ADHD Medication Product Offered

11.8.3 Amneal Pharmaceuticals ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Amneal Pharmaceuticals Main Business Overview

11.8.5 Amneal Pharmaceuticals Latest Developments

11.9 Noven Pharmaceuticals

11.9.1 Noven Pharmaceuticals Company Information

11.9.2 Noven Pharmaceuticals ADHD Medication Product Offered

11.9.3 Noven Pharmaceuticals ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Noven Pharmaceuticals Main Business Overview

11.9.5 Noven Pharmaceuticals Latest Developments

11.10 Purdue Parma

11.10.1 Purdue Parma Company Information

11.10.2 Purdue Parma ADHD Medication Product Offered

11.10.3 Purdue Parma ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Purdue Parma Main Business Overview

11.10.5 Purdue Parma Latest Developments

11.11 Zhengda Fenghai

11.11.1 Zhengda Fenghai Company Information

11.11.2 Zhengda Fenghai ADHD Medication Product Offered

11.11.3 Zhengda Fenghai ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Zhengda Fenghai Main Business Overview

11.11.5 Zhengda Fenghai Latest Developments

12 Research Findings and Conclusion

Table 1. ADHD Medication Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Stimulant

Table 3. Major Players of Non-stimulant

Table 4. ADHD Medication Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global ADHD Medication Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global ADHD Medication Market Size Market Share by Type (2017-2022)

Table 7. ADHD Medication Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global ADHD Medication Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global ADHD Medication Market Size Market Share by Application (2017-2022)

Table 10. Global ADHD Medication Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global ADHD Medication Revenue Market Share by Player (2020-2022)

Table 12. ADHD Medication Key Players Head office and Products Offered

Table 13. ADHD Medication Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global ADHD Medication Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global ADHD Medication Market Size Market Share by Regions (2017-2022)

Table 18. Americas ADHD Medication Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas ADHD Medication Market Size Market Share by Country (2017-2022)

Table 20. Americas ADHD Medication Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas ADHD Medication Market Size Market Share by Type (2017-2022)

Table 22. Americas ADHD Medication Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas ADHD Medication Market Size Market Share by Application (2017-2022)

Table 24. APAC ADHD Medication Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC ADHD Medication Market Size Market Share by Region (2017-2022)

Table 26. APAC ADHD Medication Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC ADHD Medication Market Size Market Share by Type (2017-2022)

Table 28. APAC ADHD Medication Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC ADHD Medication Market Size Market Share by Application (2017-2022)

Table 30. Europe ADHD Medication Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe ADHD Medication Market Size Market Share by Country (2017-2022)

Table 32. Europe ADHD Medication Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe ADHD Medication Market Size Market Share by Type (2017-2022)

Table 34. Europe ADHD Medication Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe ADHD Medication Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa ADHD Medication Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa ADHD Medication Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa ADHD Medication Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa ADHD Medication Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa ADHD Medication Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa ADHD Medication Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of ADHD Medication

Table 43. Key Market Challenges & Risks of ADHD Medication

Table 44. Key Industry Trends of ADHD Medication

Table 45. Global ADHD Medication Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global ADHD Medication Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global ADHD Medication Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global ADHD Medication Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global ADHD Medication Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global ADHD Medication Market Size Market Share Forecast by Application (2023-2028)

Table 51. Takeda Details, Company Type, ADHD Medication Area Served and Its Competitors

Table 52. Takeda ADHD Medication Product Offered

Table 53. Takeda ADHD Medication Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Takeda Main Business

Table 55. Takeda Latest Developments

Table 56. Johnson & Johnson Details, Company Type, ADHD Medication Area Served and Its Competitors

Table 57. Johnson & Johnson ADHD Medication Product Offered

Table 58. Johnson & Johnson Main Business

Table 59. Johnson & Johnson ADHD Medication Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Johnson & Johnson Latest Developments

Table 61. Novartis Details, Company Type, ADHD Medication Area Served and Its Competitors

Table 62. Novartis ADHD Medication Product Offered

Table 63. Novartis Main Business

Table 64. Novartis ADHD Medication Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Novartis Latest Developments

Table 66. Eli Lilly Details, Company Type, ADHD Medication Area Served and Its Competitors

Table 67. Eli Lilly ADHD Medication Product Offered

Table 68. Eli Lilly Main Business

Table 69. Eli Lilly ADHD Medication Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Eli Lilly Latest Developments

Table 71. Tris Pharma, Inc Details, Company Type, ADHD Medication Area Served and Its Competitors

Table 72. Tris Pharma, Inc ADHD Medication Product Offered

Table 73. Tris Pharma, Inc Main Business

Table 74. Tris Pharma, Inc ADHD Medication Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Tris Pharma, Inc Latest Developments

Table 76. Neos Therapeutics Details, Company Type, ADHD Medication Area Served and Its Competitors

Table 77. Neos Therapeutics ADHD Medication Product Offered

Table 78. Neos Therapeutics Main Business

Table 79. Neos Therapeutics ADHD Medication Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Neos Therapeutics Latest Developments

Table 81. Mallinckrodt Details, Company Type, ADHD Medication Area Served and Its Competitors

Table 82. Mallinckrodt ADHD Medication Product Offered

Table 83. Mallinckrodt Main Business

Table 84. Mallinckrodt ADHD Medication Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Mallinckrodt Latest Developments

Table 86. Amneal Pharmaceuticals Details, Company Type, ADHD Medication Area Served and Its Competitors

Table 87. Amneal Pharmaceuticals ADHD Medication Product Offered

Table 88. Amneal Pharmaceuticals Main Business

Table 89. Amneal Pharmaceuticals ADHD Medication Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Amneal Pharmaceuticals Latest Developments

Table 91. Noven Pharmaceuticals Details, Company Type, ADHD Medication Area Served and Its Competitors

Table 92. Noven Pharmaceuticals ADHD Medication Product Offered

Table 93. Noven Pharmaceuticals Main Business

Table 94. Noven Pharmaceuticals ADHD Medication Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Noven Pharmaceuticals Latest Developments

Table 96. Purdue Parma Details, Company Type, ADHD Medication Area Served and Its Competitors

Table 97. Purdue Parma ADHD Medication Product Offered

Table 98. Purdue Parma Main Business

Table 99. Purdue Parma ADHD Medication Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Purdue Parma Latest Developments

Table 101. Zhengda Fenghai Details, Company Type, ADHD Medication Area Served and Its Competitors

Table 102. Zhengda Fenghai ADHD Medication Product Offered

Table 103. Zhengda Fenghai ADHD Medication Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Zhengda Fenghai Main Business

Table 105. Zhengda Fenghai Latest Developments

List of Figures

Figure 1. ADHD Medication Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global ADHD Medication Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global ADHD Medication Market Size Market Share by Type in 2021

Figure 7. ADHD Medication in Attention Deficit

Figure 8. Global ADHD Medication Market: Attention Deficit (2017-2022) & ($ Millions)

Figure 9. ADHD Medication in Hyperactivity/impulse Control Disorder

Figure 10. Global ADHD Medication Market: Hyperactivity/impulse Control Disorder (2017-2022) & ($ Millions)

Figure 11. ADHD Medication in Hybrid

Figure 12. Global ADHD Medication Market: Hybrid (2017-2022) & ($ Millions)

Figure 13. Global ADHD Medication Market Size Market Share by Application in 2021

Figure 14. Global ADHD Medication Revenue Market Share by Player in 2021

Figure 15. Global ADHD Medication Market Size Market Share by Regions (2017-2022)

Figure 16. Americas ADHD Medication Market Size 2017-2022 ($ Millions)

Figure 17. APAC ADHD Medication Market Size 2017-2022 ($ Millions)

Figure 18. Europe ADHD Medication Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa ADHD Medication Market Size 2017-2022 ($ Millions)

Figure 20. Americas ADHD Medication Value Market Share by Country in 2021

Figure 21. Americas ADHD Medication Consumption Market Share by Type in 2021

Figure 22. Americas ADHD Medication Market Size Market Share by Application in 2021

Figure 23. United States ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC ADHD Medication Market Size Market Share by Region in 2021

Figure 28. APAC ADHD Medication Market Size Market Share by Application in 2021

Figure 29. China ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 33. India ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe ADHD Medication Market Size Market Share by Country in 2021

Figure 36. Europe ADHD Medication Market Size Market Share by Type in 2021

Figure 37. Europe ADHD Medication Market Size Market Share by Application in 2021

Figure 38. Germany ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 39. France ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa ADHD Medication Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa ADHD Medication Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa ADHD Medication Market Size Market Share by Application in 2021

Figure 46. Egypt ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country ADHD Medication Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 52. APAC ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 53. Europe ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 55. United States ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 56. Canada ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 57. Mexico ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 58. Brazil ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 59. China ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 60. Japan ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 61. Korea ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 63. India ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 64. Australia ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 65. Germany ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 66. France ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 67. UK ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 68. Italy ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 69. Russia ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 70. Spain ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 71. Egypt ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 72. South Africa ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 73. Israel ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 74. Turkey ADHD Medication Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries ADHD Medication Market Size 2023-2028 ($ Millions)